IP Library Granted Patent US 8,197,860
Granted Patent B2
US 8,197,860 · App. 12/424,193 · Granted Jun 12, 2012

Method for enhancing nutrient absorption with astragalosides

Assignee: Nuliv Holding Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,197,860
App. No.
12/424,193
Granted
Jun 12, 2012
Kind
B2
Abstract

The present application relates to a method for enhancing absorption of a nutrient in a subject in need thereof with an effective amount of an isolated astragaloside compound.

Claims (13)

1. A method for enhancing absorption of tryptophan in a subject in need thereof, comprising:

identifying a human subject in need of enhanced absorption of tryptophan, and

administering to the subject an effective amount of an isolated astragaloside compound for facilitating transportation of tryptophan across gut cells of the subject wherein the subject is an over-weight patient, a patient having insomnia, or a patient having long-term pressure.

2. The method of claim 1 , wherein the astragaloside compound is an astragaloside compound of Formula (A):

wherein R 1 is selected from the group consisting of H, OH, O-acetyl, O-xylopyranosyl, O-(2-acetylxylopyranosyl), O-(3-acetylxylopyranosyl), O-(2,3-diacetylxylopyranosyl), O-(2,4-diacetylxylopyranosyl), O-xylopyranosyl-(1-2)-β-D-glucopyranosyl, and O-xylopyranosyl-(1-2)-α-arabinopyranosyl; R 2 is selected from the group consisting of H, OH, O-acetyl, O-glucopyranosyl, and O-xylopyranosyl; R 3 is selected from the group consisting of H, OH, and O-acetyl; and R 4 is selected from the group consisting of

3. The method of claim 2 , wherein the astragaloside compound is selected from the group consisting of astragaloside I of Formula I:

astragaloside II of Formula II:

astragaloside III of Formula III:

astragaloside IV of Formula IV:

isoastragaloside I of Formula V:

astragaloside VI of Formula VI:

isoastragaloside II of Formula VII:

and cycloastragenol-6-O-β-D-glucopyranose of Formula VIII:

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 11, 2012
From: LIN, HANG-CHING; CHANG, WEN-LIANG; CHANG, TSU-CHUNG; DING, HSIOU-YU; WU, TIAN SHUNG
To: NULIV SCIENCE INC.
Reel/Frame 028193/0744 →
CHANGE OF NAME Recorded May 11, 2012
From: NULIV SCIENCE INC.
To: NULIV HOLDING INC.
Reel/Frame 028195/0214 →
Continuity (3)
Continuation In Part 11426029 · Jun 23, 2006
Provisional Application 60694097 · Jun 23, 2005
Related Publication 20100099633A1 · Apr 22, 2010